aIntended as a guide. Lower acquisition costs alone do not necessarily reflect a cost advantage in the outcome of the condition treated because there are other variables that affect relative costs. Formulary status is subject to change.
bManaged care plans only. Does not include Medicaid. Multiple products within the same therapeutic class may be considered preferred and on the same tier.
cFormulary data are provided by Managed Markets Insight & Technology, LLC (MMIT) and are current as of February 2022. Because formularies do change and many health plans offer more than one formulary, please check with the health plan directly to confirm coverage for individual patients.